Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

What a Pharmacist Needs to Know about Bariatric Surgery: Compounding Opportunities

Author(s):  Collier Kathleen, Beard Janet

Issue:  Mar/Apr 2005 - Health and Wellness
View All Articles in Issue

Page(s):  111-115

What a Pharmacist Needs to Know about Bariatric Surgery: Compounding Opportunities Page 1
What a Pharmacist Needs to Know about Bariatric Surgery: Compounding Opportunities Page 2
What a Pharmacist Needs to Know about Bariatric Surgery: Compounding Opportunities Page 3
What a Pharmacist Needs to Know about Bariatric Surgery: Compounding Opportunities Page 4
What a Pharmacist Needs to Know about Bariatric Surgery: Compounding Opportunities Page 5

Download in electronic PDF format for $65

Abstract:  Approximately two thirds of adults in the United States are overweight or obese. The National Institutes of Health report that obesity is associated with higher rates of morbidity and mortality. Healthcare spending for obese persons is 37% higher than spending for individuals of healthy weight. Losing weight decreases the risk of diabetes, hyperlipidemia, and cardiovascular disease, as well as other chronic diseases. Weight-loss surgery, also known as bariatric surgery, is usually limited to the morbidly obese, those with a body mass index (BMI) = 40, or = 35 with some comorbid conditions. Bariatric surgery involves reducing the size of the gastric reservoir to decrease the amount of calories the patient is able to ingest. The surgery is considered not a cosmetic procedure but the only proven method to achieve long-term weight control for the severely obese, when accompanied by lifestyle and behavior modifications. Of primary concern to pharmacists for patients who have undergone bariatric surgery are drugs that may potentially harm the stomach pouch that remains after surgery, nutritional deficiencies, and dumping syndrome. Decreased acid in the stomach pouch affects the patient’s ability to process drugs and nutrition. One of the most common problems following bariatric surgery is calcium deficiency. Patients who have undergone bariatric surgery present numerous compounding opportunities in the areas of nutrition, pain management, electrolyte balance, hair loss, and skin problems, among others.

Related Keywords: Kathleen Collier, Janet Beard, obesity, weight loss, malabsorption, nutritional deficiency, body mass index, BMI, dumping syndrome

Related Categories: GASTROENTEROLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
What a Pharmacist Needs to Know about Bariatric Surgery: Compounding Opportunities
Collier Kathleen
, Beard Janet
Mar/Apr 2005
Pg. 111-115

Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients
McElhiney Linda F
Jan/Feb 2018
Pg. 30-39

Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know
Lanze Amanda
, Rudner Shara
Sep/Oct 2014
Pg. 397-399

Wilson's Syndrome and T3 Therapy
Milner Martin
Sep/Oct 1999
Pg. 344-348

Calculations
Stockton Shelly J
Sep/Oct 2014
Pg. 407

Calculations
Stockton Shelly J
Mar/Apr 2016
Pg. 142

Calculations
Stockton Shelly J
Sep/Oct 2017
Pg. 406

Calculations
Stockton Shelly J
Jul/Aug 2013
Pg. 324

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Providing Consultation Services for Wellness Issues Related to Exercise, Weight Management, and Nutritional Support: Key Lifestyle Modification for Healthier Aging
Biundo Bruce
Jan/Feb 2010
Pg. 26-31

Three Things You Need to Know Right Now
Brunner Scott
May/Jun 2022
Pg. 211-213

Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)
Riepl Mike
May/Jun 2019
Pg. 192-199

Calculations
Stockton Shelly J
Jan/Feb 2007
Pg. 68

Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome
Mathews Elizabeth
Sep/Oct 2000
Pg. 334

Equine Cushing’s Syndrome
Vail Jane
Jan/Feb 2003
Pg. 27-29

Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity
Biundo Bruce
, Gogola Margaret
Jul/Aug 2015
Pg. 289-293

The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Parks Kenneth Chase
, Bernard Brian, Cogdill Christopher Blake
Sep/Oct 2015
Pg. 377-380

Calculations
Stockton Shelly J
May/Jun 2019
Pg. 229

Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume
Allen Loyd V Jr
Mar/Apr 2014
Pg. 131-134

Sport Body Cooler
Allen Loyd V Jr
May/Jun 2011
Pg. 247